Large-scale testing (Phase 3)Study completedNCT00770913
What this trial is testing
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
Who this might be right for
Refractory Reflux Esophagitis
Eisai Co., Ltd. 337